Kruse M - Search Results

1

Cost effectiveness of denosumab versus oral bisphosphonates for postmenopausal osteoporosis in the US.

Parthan A, Kruse M, Yurgin N, Huang J, Viswanathan HN, Taylor D. Parthan A, et al. Among authors: kruse m. Appl Health Econ Health Policy. 2013 Oct;11(5):485-97. doi: 10.1007/s40258-013-0047-8. Appl Health Econ Health Policy. 2013. PMID: 23868102

2

Denosumab: a cost-effective alternative for older men with osteoporosis from a Swedish payer perspective.

Parthan A, Kruse M, Agodoa I, Silverman S, Orwoll E. Parthan A, et al. Among authors: kruse m. Bone. 2014 Feb;59:105-13. doi: 10.1016/j.bone.2013.11.002. Epub 2013 Nov 12. Bone. 2014. PMID: 24231131

3

Denosumab for Elderly Men with Osteoporosis: A Cost-Effectiveness Analysis from the US Payer Perspective.

Silverman S, Agodoa I, Kruse M, Parthan A, Orwoll E. Silverman S, et al. Among authors: kruse m. J Osteoporos. 2015;2015:627631. doi: 10.1155/2015/627631. Epub 2015 Dec 9. J Osteoporos. 2015. PMID: 26783494 Free PMC article.

4

A Model for Assessing the Clinical and Economic Benefits of Bone-forming Agents for Reducing Fractures in Postmenopausal Women at High, Near-term Risk of Osteoporotic Fracture.

O'Hanlon CE, Parthan A, Kruse M, Cartier S, Stollenwerk B, Jiang Y, Caloyeras JP, Crittenden DB, Barron R. O'Hanlon CE, et al. Among authors: kruse m. Clin Ther. 2017 Jul;39(7):1276-1290. doi: 10.1016/j.clinthera.2017.05.348. Epub 2017 Jun 17. Clin Ther. 2017. PMID: 28629610 Free article.

5

Comparison of different adjuvant therapies for 9 resectable cancer types.

Kruse M, Parthan A, Coombs J, Sasane M, Taylor D. Kruse M, et al. Postgrad Med. 2013 Mar;125(2):83-91. doi: 10.3810/pgm.2013.03.2643. Postgrad Med. 2013. PMID: 23816774 Review.

6

Cost-Effectiveness Analysis of Treating Acute Promyelocytic Leukemia Patients With Arsenic Trioxide and Retinoic Acid in the United States.

Tallman M, Lo-Coco F, Barnes G, Kruse M, Wildner R, Martin M, Mueller U, Tang B. Tallman M, et al. Among authors: kruse m. Clin Lymphoma Myeloma Leuk. 2015 Dec;15(12):771-7. doi: 10.1016/j.clml.2015.07.634. Epub 2015 Aug 5. Clin Lymphoma Myeloma Leuk. 2015. PMID: 26361645 Free PMC article.

7

Review of seasonal influenza in Canada: Burden of disease and the cost-effectiveness of quadrivalent inactivated influenza vaccines.

Thommes EW, Kruse M, Kohli M, Sharma R, Noorduyn SG. Thommes EW, et al. Among authors: kruse m. Hum Vaccin Immunother. 2017 Apr 3;13(4):867-876. doi: 10.1080/21645515.2016.1251537. Epub 2016 Nov 18. Hum Vaccin Immunother. 2017. PMID: 27858509 Free PMC article. Review.

8

Cost of Treating Acute Promyelocytic Leukemia (APL) Patients in Italy.

Kruse MM, Wildner R, Barnes G, Martin M, Mueller U, Lo Coco F, Leyman S, Pathak A. Kruse MM, et al. Value Health. 2014 Nov;17(7):A624. doi: 10.1016/j.jval.2014.08.2218. Epub 2014 Oct 26. Value Health. 2014. PMID: 27202202 Free article. No abstract available.

9

Budgetary impact of treating acute promyelocytic leukemia patients with first-line arsenic trioxide and retinoic acid from an Italian payer perspective.

Kruse M, Wildner R, Barnes G, Martin M, Mueller U, Lo-Coco F, Pathak A. Kruse M, et al. PLoS One. 2015 Aug 12;10(8):e0134587. doi: 10.1371/journal.pone.0134587. eCollection 2015. PLoS One. 2015. PMID: 26267454 Free PMC article.

10

Systematic review of guidelines for care of intersex people in the emergency department.

Kruse MI, Baas-Sylvester K, Wildeman V, Clarizio A, Upadhye S, Bigham BL. Kruse MI, et al. CJEM. 2025 Jan 10. doi: 10.1007/s43678-024-00797-y. Online ahead of print. CJEM. 2025. PMID: 39792321

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,013 results

Search Page

Filters